TY - JOUR
T1 - Renal sodium and magnesium reabsorption are not coupled in a mouse model of Gordon syndrome
AU - van Megen, Wouter H.
AU - Grimm, Paul R.
AU - Welling, Paul A.
AU - van der Wijst, Jenny
N1 - Funding Information:
Funding Information WHM is supported by the Dutch Kidney Foundation Kolff fellowship abroad grant (16OKK61). JW is supported by the European Union's Horizon 2020 Marie Skłodowska-Curie (grant agreement No 748058) and by The Netherlands Organisation for Health Research and Development (Off Road grant 451001 004). The work was performed in the laboratory of PAW and supported by funds from the NIDDK, DK054231 DK093501. The authors express their gratitude to Dr. Boyoung Kim for technical support.
Funding Information:
WHM is supported by the Dutch Kidney Foundation Kolff fellowship abroad grant (16OKK61). JW is supported by the European Union’s Horizon 2020 Marie Skłodowska-Curie (grant agreement No 748058) and by The Netherlands Organisation for Health Research and Development (Off Road grant 451001 004). The work was performed in the laboratory of PAW and supported by funds from the NIDDK, DK054231 DK093501.
Publisher Copyright:
© 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.
PY - 2018/7
Y1 - 2018/7
N2 - Active reabsorption of magnesium (Mg 2+ ) in the distal convoluted tubule (DCT) of the kidney is crucial for maintaining Mg 2+ homeostasis. Impaired activity of the Na + -Cl − -cotransporter (NCC) has been associated with hypermagnesiuria and hypomagnesemia, while increased activity of NCC, as observed in patients with Gordon syndrome, is not associated with alterations in Mg 2+ balance. To further elucidate the possible interrelationship between NCC activity and renal Mg 2+ handling, plasma Mg 2+ levels and urinary excretion of sodium (Na + ) and Mg 2+ were measured in a mouse model of Gordon syndrome. In this model, DCT1-specific expression of a constitutively active mutant form of the NCC-phosphorylating kinase, SPAK (CA-SPAK), increases NCC activity and hydrochlorothiazide (HCTZ)-sensitive Na + reabsorption. These mice were normomagnesemic and HCTZ administration comparably reduced plasma Mg 2+ levels in CA-SPAK mice and control littermates. As inferred by the initial response to HCTZ, CA-SPAK mice exhibited greater NCC-dependent Na + reabsorption together with decreased Mg 2+ reabsorption, compared to controls. Following prolonged HCTZ administration (4 days), CA-SPAK mice exhibited higher urinary Mg 2+ excretion, while urinary Na + excretion decreased to levels observed in control animals. Surprisingly, CA-SPAK mice had unaltered renal expression of Trpm6, encoding the Mg 2+ -permeable channel TRPM6, or other magnesiotropic genes. In conclusion, CA-SPAK mice exhibit normomagnesemia, despite increased NCC activity and Na + reabsorption. Thus, Mg 2+ reabsorption is not coupled to increased thiazide-sensitive Na + reabsorption, suggesting a similar process explains normomagnesemia in Gordon syndrome. Further research is required to unravel the molecular underpinnings of this phenomenon and the more pronounced Mg 2+ excretion after prolonged HCTZ administration.
AB - Active reabsorption of magnesium (Mg 2+ ) in the distal convoluted tubule (DCT) of the kidney is crucial for maintaining Mg 2+ homeostasis. Impaired activity of the Na + -Cl − -cotransporter (NCC) has been associated with hypermagnesiuria and hypomagnesemia, while increased activity of NCC, as observed in patients with Gordon syndrome, is not associated with alterations in Mg 2+ balance. To further elucidate the possible interrelationship between NCC activity and renal Mg 2+ handling, plasma Mg 2+ levels and urinary excretion of sodium (Na + ) and Mg 2+ were measured in a mouse model of Gordon syndrome. In this model, DCT1-specific expression of a constitutively active mutant form of the NCC-phosphorylating kinase, SPAK (CA-SPAK), increases NCC activity and hydrochlorothiazide (HCTZ)-sensitive Na + reabsorption. These mice were normomagnesemic and HCTZ administration comparably reduced plasma Mg 2+ levels in CA-SPAK mice and control littermates. As inferred by the initial response to HCTZ, CA-SPAK mice exhibited greater NCC-dependent Na + reabsorption together with decreased Mg 2+ reabsorption, compared to controls. Following prolonged HCTZ administration (4 days), CA-SPAK mice exhibited higher urinary Mg 2+ excretion, while urinary Na + excretion decreased to levels observed in control animals. Surprisingly, CA-SPAK mice had unaltered renal expression of Trpm6, encoding the Mg 2+ -permeable channel TRPM6, or other magnesiotropic genes. In conclusion, CA-SPAK mice exhibit normomagnesemia, despite increased NCC activity and Na + reabsorption. Thus, Mg 2+ reabsorption is not coupled to increased thiazide-sensitive Na + reabsorption, suggesting a similar process explains normomagnesemia in Gordon syndrome. Further research is required to unravel the molecular underpinnings of this phenomenon and the more pronounced Mg 2+ excretion after prolonged HCTZ administration.
KW - Gordon syndrome
KW - kidney
KW - magnesium
KW - sodium
UR - http://www.scopus.com/inward/record.url?scp=85050795814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050795814&partnerID=8YFLogxK
U2 - 10.14814/phy2.13728
DO - 10.14814/phy2.13728
M3 - Article
C2 - 30030908
AN - SCOPUS:85050795814
SN - 2051-817X
VL - 6
JO - Physiological Reports
JF - Physiological Reports
IS - 14
M1 - e13728
ER -